Encoded closes $275M Series F to advance Dravet syndrome drug ETX101 on September 10, 2026 ETX101 gene therapy Granulovirus Infantile Severe Myoclonic Epilepsy manufacturing neurology pipeline SCN1A gene Series F +
Encoded raises $275M to push Dravet gene therapy toward registration on September 09, 2026 AAV9 ETX101 ETX301 gene therapy GMP manufacturing Granulovirus Infantile Severe Myoclonic Epilepsy SCN1A gene Series F +
Innovaccer in the News: $250M Funding Talks and AI Expansion on August 13, 2026 agentic AI platform funding round Innovaccer Series F +
Rakuten Medical Raises $100 Million in Oversubscribed Series F for Photoimmunotherapy Platform on January 07, 2026 Alluminox Cancer Therapeutic Procedure methionine Photoimmunotherapy Rakuten Medical regulatory approval Series F +